Newsletter Archive

31. 06.16.25 -- Will Genome Modifications Define Next-Gen AAV Vectors? 6/16/2025
    06/16/25 Bioprocess Online Newsletter
32. 06.14.25 -- Bioprocess Online Best Of May 6/14/2025
    06/14/25 Bioprocess Online Newsletter
33. 06.13.25 -- STREAM Edition: Do Novel Workflows Increase Regulatory Scrutiny? 6/13/2025

    06/13/25 Bioprocess Online Newsletter

34. 06.13.25 -- The 3 Phases Of QRM – An Inspector's View 6/13/2025
    06/13/25 Bioprocess Online Newsletter
35. 06.12.25 -- Validation, PAT, And AI In Fed-Batch And Continuous Environments 6/12/2025
    06/12/25 Bioprocess Online Newsletter
36. 06.11.25 -- Increase Your Biologic's Chances Of Clinical Success: Data-Driven Strategies 6/11/2025

    06/11/25 Bioprocess Online Newsletter

37. 06.11.25 -- Formulation Is Key For Y-mAbs' Self-Assembling Antibody 6/11/2025
    06/11/25 Bioprocess Online Newsletter
38. 06.10.25 -- Unlocking Bioprocess Productivity-Upstream Intensification 6/10/2025

    06/10/25 Bioprocess Online Newsletter

39. 06.10.25 -- Is The Future Of Gene Delivery Non-Viral? 6/10/2025

    06/10/25 Bioprocess Online Newsletter

40. 06.10.25 -- The Matryoshka Model: The New Face Of Contract Packaging In Pharma 6/10/2025
    06/10/25 Bioprocess Online Newsletter